The Financial Crimes Enforcement Network says the two-year delay will give it time to review and potentially limit the scope ...
The amendment, codified under document number 2025-24184, alters the Anti-Money Laundering/Countering the Financing of ...
Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
Two of the largest organizations representing investment advisers and asset managers are voicing support for a federal proposal to postpone new anti-money laundering requirements for RIAs, while ...
Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros’ OncotoX biologics program focused on acute myeloid leukemia ...
A detailed to-do list for SEC-registered firms to build a foundation for compliant and effective anti-money laundering ...
In financial institutions across the United States, there’s a reflex that’s become almost ritual. When a regulator walks in, or a board member asks whether the AML program is working, the answer is ...
The meeting emphasized the importance of preventing money laundering and terrorist financing in establishing sound corporate ...
– The Steering Committee brings together distinguished clinical experts in AML from leading National Comprehensive Cancer Network Centers – SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback